Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation - A serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial

被引:80
作者
Weissman, NJ
Koglin, J
Cox, DA
Hermiller, J
O'Shaughnessy, C
Mann, JT
Turco, M
Caputo, R
Bergin, P
Greenberg, J
Kutcher, M
Wong, SC
Strickland, W
Mooney, M
Russell, ME
Ellis, SG
Stone, GW
机构
[1] Washington Hosp Ctr, Washington, DC 20010 USA
[2] Boston Sci Corp, Natick, MA USA
[3] Mid Carolina Cardiol, Charlotte, NC USA
[4] St Vincents Hosp, Indianapolis, IN USA
[5] Elyria Mem Hosp, Elyria, OH USA
[6] WakeMed, Raleigh, NC USA
[7] Washington Adventist Hosp, Takoma Pk, MD USA
[8] St Josephs Hosp, Syracuse, NY USA
[9] Sacred Heart Med Ctr, Eugene, OR USA
[10] Florida Hosp, Orlando, FL USA
[11] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA
[12] New York Presbyterian Hosp, New York, NY USA
[13] Huntsville Dist Mem Hosp, Huntsville, AL USA
[14] Abbott NW Hosp, Minneapolis, MN 55407 USA
[15] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[16] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[17] Cardiovasc Res Fdn, New York, NY USA
关键词
D O I
10.1016/j.jacc.2004.10.078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to use serial volumetric intravascular ultrasound (IVUS) to evaluate the effects of polymer-based, paclitaxel-eluting stents on in-stent neointima formation and late incomplete stent apposition. BACKGROUND The TAXUS-IV trial demonstrated that the slow-release, polymer-based, paclitaxel-eluting stent reduces angiographic restenosis and the need for repeat revascularization procedures. Serial IVUS studies reveal details of the pattern of vascular responses provoked by stent implantation that provide insight into device safety and efficacy. METHODS In the TAXUS-IV trial, patients were randomized to the slow-release, polymer-based, paclitaxel-eluting TAXUS stent or a bare-metal EXPRESS stent (Boston Scientific Corp., Natick, Massachusetts). As part of a formal substudy, complete volumetric IVUS data were available in 170 patients, including 88 TAXUS patients and 82 controls, at implantation and at nine-month follow-up. RESULTS No baseline differences were present in the clinical characteristics or IVUS parameters between the control and TAXUS groups. At nine-month follow-up, IVUS lumen volumes were larger in the TAXUS group (123 +/- 43 mm(3) vs. 104 +/- 44 mm(3), p = 0.005), due to a reduction in neointimal volume (18 +/- 18 mm(3) vs. 41 +/- 23 mm(3), p < 0.001). Millimeter-by-millimeter analysis within the stent demonstrated uniform suppression of neointimal growth along the entire stent length. Late lumen loss was similar at the proximal edge of the stent between the two groups, and reduced with the TAXUS stent at the distal. edge (p = 0.004). Incomplete stent apposition at nine months was observed in only 3.0% of control and 4.0% of TAXUS stents (p = 0.12). CONCLUSIONS Polymer-based, paclitaxel-eluting TAXUS stents are effective in inhibiting neointimal tissue proliferation, and do not result in late incomplete stent apposition.
引用
收藏
页码:1201 / 1205
页数:5
相关论文
共 9 条
[1]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[2]   Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation [J].
Hong, MK ;
Mintz, GS ;
Lee, CW ;
Kim, YH ;
Lee, SW ;
Song, JM ;
Han, KH ;
Kang, DH ;
Song, JK ;
Kim, JJ ;
Park, SW ;
Park, SJ .
CIRCULATION, 2004, 109 (07) :881-886
[3]   Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries - A serial volumetric intravascular ultrasound analysis from the ASian paclitaxel-eluting stent clinical trial (ASPECT) [J].
Hong, MK ;
Mintz, GS ;
Lee, CW ;
Song, JM ;
Han, KH ;
Kang, DH ;
Song, JK ;
Kim, JJ ;
Weissman, NJ ;
Fearnot, NE ;
Park, SW ;
Park, SJ .
CIRCULATION, 2003, 107 (04) :517-520
[4]   Regional remodeling as the cause of late stent malapposition [J].
Mintz, GS ;
Shah, VM ;
Weissman, NJ .
CIRCULATION, 2003, 107 (21) :2660-2663
[5]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[6]   Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J].
Moses, JW ;
Leon, MB ;
Popma, JJ ;
Fitzgerald, PJ ;
Holmes, DR ;
O'Shaughnessy, C ;
Caputo, RP ;
Kereiakes, DJ ;
Williams, DO ;
Teirstein, PS ;
Jaeger, JL ;
Kuntz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1315-1323
[7]   Vascular responses at proximal and distal edges of paclitaxel-eluting stents - Serial intravascular ultrasound analysis from the TAXUS II trial [J].
Serruys, PW ;
Degertekin, M ;
Tanabe, K ;
Russell, ME ;
Guagliumi, G ;
Webb, J ;
Hamburger, J ;
Rutsch, W ;
Kaiser, C ;
Whitbourn, R ;
Camenzind, E ;
Meredith, I ;
Reeves, F ;
Nienaber, C ;
Benit, E ;
Disco, C ;
Koglin, J ;
Colombo, A .
CIRCULATION, 2004, 109 (05) :627-633
[8]   Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial [J].
Serruys, PW ;
Degertekin, M ;
Tanabe, K ;
Abizaid, A ;
Sousa, JE ;
Colombo, A ;
Guagliumi, G ;
Wijns, W ;
Lindeboom, WK ;
Ligthart, J ;
de Feyter, PJ ;
Morice, MC .
CIRCULATION, 2002, 106 (07) :798-803
[9]   A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease [J].
Stone, GW ;
Ellis, SG ;
Cox, DA ;
Hermiller, J ;
O'Shaughnessy, C ;
Mann, JT ;
Turco, M ;
Caputo, R ;
Bergin, P ;
Greenberg, J ;
Popma, JJ ;
Russell, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (03) :221-231